Filter
440
Filtered Results: 440
Text search:
National
Institute
for
Viral
Disease
Control
and
Prevention,
China
Featured
Recommendations
61
New Publications
64
Language
Document type
No document type
157
Guidelines
129
Studies & Reports
82
Manuals
31
Strategic & Response Plan
18
Fact sheets
11
Situation Updates
5
Training Material
4
Resource Platforms
2
Infographics
1
Countries / Regions
Global
19
India
15
South Africa
13
Brazil
10
Western and Central Europe
10
Latin America and the Carribbean
8
Africa
8
Germany
7
Russia
7
Vietnam
6
Kenya
5
Mozambique
5
Peru
4
Colombia
4
Ecuador
4
Bolivia
4
Angola
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Asia
4
Spain
4
Guinea-Bissau
3
Uganda
3
Syria
3
China
3
Ukraine
3
Myanmar / Burma
3
East and Southern Africa
3
Eastern Europe
3
Portugal
3
Guinea
2
Ethiopia
2
Pakistan
2
Bangladesh
2
Papua New Guinea
2
Namibia
2
Venezuela
2
Laos
2
France
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Ghana
1
Zimbabwe
1
South Sudan
1
Jordan
1
Turkey
1
Tanzania
1
Cambodia
1
Thailand
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
North Macedonia
1
Honduras
1
Botswana
1
El Salvador
1
Mexico
1
Chile
1
Yemen
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Albania
1
North America
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
116
Clinical Guidelines
62
Public Health
18
Women & Child Health
9
Key Resources
8
Pharmacy & Technologies
7
Capacity Building
2
Toolboxes
COVID-19
142
HIV
77
Rapid Response
28
TB
19
AMR
17
Mental Health
15
Planetary Health
15
Ebola
10
Global Health Education
9
NCDs
8
Refugee
7
NTDs
7
Specific Hazards
5
Disability
4
Pharmacy
4
Polio
3
Conflict
2
Natural Hazards
2
Zika
2
Health Financing Toolbox
2
Cholera
1
Health Financing
1
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-ri...
Supplement October 2010
HIV/AIDS, security and conflict: making the connections
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
This revision to the Disaster Management Team’s (DMT) multi-sector response plan for COVID-19 is meant to align the multi-sector plan with the Department of Health’s COVID-19 Emergency Response Plan issued on 24 April 2020.
Recommendations for the management of oncology patients during the SARS-CoV-2/Covid-19 pandemic
Guia de procedimientos de bioseguridad para la consulta odontologica durant la pandemia por COVID-19
Guide to bio-safety procedures for dental practices during the COVID-19 pandemic
Brief review of selected topics
The following pages provide a focus on selected areas in relation to neurology. The specialists who contributed the reviews are listed in the Project Team and Partners
Neurology Atlas (2004)
Consensual Recommendation for treatment of COVID-19 in older adults
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequen...
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequen...
UNAIDS report on the global AIDS epidemic shows that 2020 targets will not be met because of deeply unequal success; COVID-19 risks blowing HIV progress way off course. Missed targets have resulted in 3.5 million more HIV infections and 820 000 more...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack...
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t...
Obejtivo General:
Establecer las directrices de vigilancia epidemiológica y laboratorio de COVID-19
dentro del Sistema Nacional de Vigilancia, que permita detectar los casos en el país y
evaluar los riesgos para generar información epidemio...
The UNAIDS 2020 global report is a call to action. It highlights the scale of the HIV epidemic and how it runs along the fault lines of inequalities.
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, ... reduce the time to diagnosis. WHO-recommended rapid diagnostics are highly accurate, cost-effective, reduce the time to treatment initiation, and impact patient-important outcomes.
